EUVIMEDEUVIMED entdecken
Crossref

NIR-II Imaging-Guided Phototherapy-Induced Senescence Reprograms Immunosuppressive Tumor Microenvironment for Potent Cancer Immunotherapy

Zifan Yang, Xinwen Ou, Zhuomin Tang, Zhongwen Nong, Xiuxin Lu, Xinglong Zhang, Meng Suo, Zixiang Meng, Shiquan Deng, Ping Shangguan, Tianfu Zhang iD, Ben Zhong Tang iD und 1 weitere

ACS Nano · 2026

DOI: 10.1021/acsnano.6c03475 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Zifan Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, The Second Affiliated Hospital of Guangxi Medical University, Nanning 530000, China. Hauptthemen laut MEDLINE: Immunotherapy, Tumor Microenvironment, Cellular Senescence, Phototherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Research Grants Council, University Grants Committee, Special Project for Research and Development in Key areas of Guangdong Province, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyTumor MicroenvironmentCellular SenescencePhototherapyTriple Negative Breast NeoplasmsAntineoplastic AgentsAnimalsHumansInfrared RaysFemaleMiceCell Line, Tumor

Stichwörter der Autor:innen

aggregation-induced emissionbreast cancercancer immunotherapyphototherapysenescence

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Breast Surgery, The Second Affiliated Hospital of Guangxi Medical University, Nanning 530000, China.
  • Hong Kong Branch of Chinese National Engineering Research Center for Tissue Restoration and Reconstruction, Department of Chemistry, Department of Chemical and Biological Engineering, and State Key Laboratory of Molecul…
  • Research Center of Nanomedicine Technology, The Second Affiliated Hospital of Guangxi Medical University, Nanning 530000, China.
  • Guangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, School of Biomedical Engineering, Guangzhou Medical University, Guangzhou, Guangdong 511436, China.
  • Guangdong Basic Research Center of Excellence for Aggregate Science, School of Science and Engineering, The Chinese University of Hong Kong (Shenzhen), Longgang, Shenzhen, Guangdong 518172, China.

ORCID-Profile: Tianfu Zhang, Ben Zhong Tang

Förderung

  • Research Grants Council, University Grants Committee
  • Special Project for Research and Development in Key areas of Guangdong Province
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Natural Science Foundation of Guangxi Zhuang Autonomous Region
  • Science and Technology Department of Guangxi Zhuang Autonomous
  • Shenzhen Science and Technology Innovation Commission
  • National Basic Research Program of China (973 Program)
  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Yang, Z., Ou, X., Tang, Z., Nong, Z., Lu, X., Zhang, X., Suo, M., Meng, Z., Deng, S., Shangguan, P., Zhang, T., Tang, B. Z., & Ning, S. (2026). NIR-II Imaging-Guided Phototherapy-Induced Senescence Reprograms Immunosuppressive Tumor Microenvironment for Potent Cancer Immunotherapy. ACS Nano. https://doi.org/10.1021/acsnano.6c03475

Vancouver

Yang Z, Ou X, Tang Z, Nong Z, Lu X, Zhang X, et al. NIR-II Imaging-Guided Phototherapy-Induced Senescence Reprograms Immunosuppressive Tumor Microenvironment for Potent Cancer Immunotherapy. ACS Nano. 2026. doi:10.1021/acsnano.6c03475

BibTeX
@article{Yang2026,
  author = {Yang, Zifan and Ou, Xinwen and Tang, Zhuomin and Nong, Zhongwen and Lu, Xiuxin and Zhang, Xinglong and Suo, Meng and Meng, Zixiang and Deng, Shiquan and Shangguan, Ping and Zhang, Tianfu and Tang, Ben Zhong and Ning, Shipeng},
  title = {NIR-II Imaging-Guided Phototherapy-Induced Senescence Reprograms Immunosuppressive Tumor Microenvironment for Potent Cancer Immunotherapy},
  journal = {ACS Nano},
  year = {2026},
  doi = {10.1021/acsnano.6c03475}
}
Kostenlos starten →